Bastyr University
Kenmore, Washington, 98028, United States
Location status: Recruiting
Location contact
Laurie K Mischley, ND, PhD, MPH
CONTACT
Laurie K Mischley, ND, PhD, MPH
PRINCIPAL_INVESTIGATOR
NCT Number: NCT02194816
We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate, we will ask participants to fill our questionnaires about their experience with PD, their health in general, along with their food intake every six months for five years.
Interested in participating?
Request Info19 year and older
All sexes
Observational
Kenmore, Washington, 98028, United States
Location status: Recruiting
Laurie K Mischley, ND, PhD, MPH
CONTACT
Laurie K Mischley, ND, PhD, MPH
PRINCIPAL_INVESTIGATOR
This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits among patients with Parkinson's disease (PD). This study will identify and describe those individuals with the highest quality of life and least amount of disease activity, in order to describe medication, diet, and lifestyle patterns associated with a lack of PD disease progression and high quality of life.
Participants will be asked to complete online surveys every six months for five years. The time requirement is about an hour to an hour and a half every six months. Participants do not need to answer questions if they do not feel comfortable answering.
At each six month time point we will send participants an email with the link to the CAM Care in PD survey, a questionnaire about health and wellbeing (completed in REDCap). After participants have completed this survey we will send participants a link to the second survey, about dietary intake (completed on ASA24.gov). Because there is a designated window of time during which surveys must be completed, participants may receive a gentle reminder from us if time is running out.
This study is not designed to provide care. Participants are encouraged to consult with any providers you wish. Participants will not directly benefit from the study, but information gathered during the course of this study may help us begin to assess the longer-term effects of complementary and integrative care on health, disease progression and quality of life in PD patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with PD. Results will be reported with descriptive statistics.
Time frame: 5 years
This outcome measure will be used to assess general health and well-being in the cohort.
Time frame: 5 years
This outcome measure is a series of 33 slider bars, developed for this study, to evaluate the individual's perception of symptom severity. The cumulative score for all 33 listed symptoms will be reported as the PRO-PD score.
Time frame: 5 years
Participants will be given 'free space' to provide additional information they consider relevant.
Contact information is provided by the study sponsor or research team.
Bastyr University
Other
Modifiable Variables in Parkinsonism (MVP) [Formerly CAM Care in PD]
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02994719
Ataxia, Ataxia, Spinocerebellar
Boston, Massachusetts, United States
View Trial DetailsNCT07570212
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT02874274
Basal Ganglia Diseases, Brain Diseases
New York, United States
View Trial DetailsNCT02761707
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial Details